IMMX — IMMIX BIOPHARMA INC

Ownership history in Focus Partners Wealth  ·  6 quarters on record

This page tracks every 13F SEC filing in which Focus Partners Wealth reported a position in IMMIX BIOPHARMA INC (IMMX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 UNCHANGED 11,900 — 0% 0.00% $25K $2.09
2025 Q2 UNCHANGED 11,900 — 0% 0.00% $25K $2.07
2025 Q1 UNCHANGED 11,900 — 0% 0.00% $20K $1.68
2024 Q4 UNCHANGED 11,900 — 0% 0.00% $26K $2.20
2 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    IMMX price (monthly, adj. close)

Other funds also holding IMMX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 2.88% Bleichroeder LP 3Y 0.92% Imprint Wealth LLC 0.49% Blue Owl Capital Holdings LP 3Y 0.39% Logos Global Management LP 3Y 0.32% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.21% Velan Capital Investment Management LP 3Y 0.11% Burkehill Global Management, LP 0.1% Persistent Asset Partners Ltd 0.07% Informed Momentum Co LLC 3Y 7Y 0.07%
← Back to Focus Partners Wealth Holdings